BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24439205)

  • 1. Chemical biology approaches to designing defined carbohydrate vaccines.
    Anish C; Schumann B; Pereira CL; Seeberger PH
    Chem Biol; 2014 Jan; 21(1):38-50. PubMed ID: 24439205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of glycomics, glycan arrays and carbohydrate-based vaccines.
    Lepenies B; Seeberger PH
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):196-207. PubMed ID: 20141495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of carbohydrate-based vaccines.
    Khatun F; Toth I; Stephenson RJ
    Adv Drug Deliv Rev; 2020; 165-166():117-126. PubMed ID: 32320714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the immune efficacy of carbohydrate vaccines by chemical modification on the GM3 antigen.
    Zheng XJ; Yang F; Zheng M; Huo CX; Zhang Y; Ye XS
    Org Biomol Chem; 2015 Jun; 13(22):6399-406. PubMed ID: 25982227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
    Adamo R
    Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate chemistry in drug discovery.
    Galan MC; Benito-Alifonso D; Watt GM
    Org Biomol Chem; 2011 May; 9(10):3598-610. PubMed ID: 21409288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.
    Nyame AK; Kawar ZS; Cummings RD
    Arch Biochem Biophys; 2004 Jun; 426(2):182-200. PubMed ID: 15158669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines based on structure-based design provide protection against infectious diseases.
    Thomas S; Luxon BA
    Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient convergent synthesis of bi-, tri-, and tetra-antennary complex type N-glycans and their HIV-1 antigenicity.
    Shivatare SS; Chang SH; Tsai TI; Ren CT; Chuang HY; Hsu L; Lin CW; Li ST; Wu CY; Wong CH
    J Am Chem Soc; 2013 Oct; 135(41):15382-91. PubMed ID: 24032650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate.
    Liu X; Siegrist S; Amacker M; Zurbriggen R; Pluschke G; Seeberger PH
    ACS Chem Biol; 2006 Apr; 1(3):161-4. PubMed ID: 17163663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Design of Synthetic B Cell Epitopes for Carbohydrate-Based Vaccines.
    Broecker F; Seeberger PH
    Methods Enzymol; 2017; 597():311-334. PubMed ID: 28935109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic GPI array to study antitoxic malaria response.
    Kamena F; Tamborrini M; Liu X; Kwon YU; Thompson F; Pluschke G; Seeberger PH
    Nat Chem Biol; 2008 Apr; 4(4):238-40. PubMed ID: 18311131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies in the Design and Use of Synthetic "Internal Glycan" Vaccines.
    Lakshminarayanan A; Vijayakrishnan B; Bayley H; Davis BG
    Methods Enzymol; 2017; 597():335-357. PubMed ID: 28935110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycans in Medicinal Chemistry: An Underexploited Resource.
    Fernández-Tejada A; Cañada FJ; Jiménez-Barbero J
    ChemMedChem; 2015 Aug; 10(8):1291-5. PubMed ID: 25974358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glycan Array Platform as a Tool to Identify Carbohydrate Antigens.
    Xia L; Gildersleeve JC
    Methods Mol Biol; 2015; 1331():27-40. PubMed ID: 26169733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopolymers and glyco-nanoparticles in biomolecular recognition processes and vaccine development.
    Sunasee R; Narain R
    Macromol Biosci; 2013 Jan; 13(1):9-27. PubMed ID: 23042762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers for vaccine and immunostimulatory uses. A review.
    Heegaard PM; Boas U; Sorensen NS
    Bioconjug Chem; 2010 Mar; 21(3):405-18. PubMed ID: 19886668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines.
    Roy R; Shiao TC
    Chimia (Aarau); 2011; 65(1-2):24-9. PubMed ID: 21469440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.